Predictive impact of ARID1A status in solid tumors

被引：0
|
作者：
Ampanattu, S. Daniel [1 ]
Ahmed, G. [1 ]
Thapa, B. [1 ]
Janardan, A. [2 ]
Vallejos, A. [3 ]
Taylor, B. [3 ]
Huaying, D. [4 ]
Szabo, A. [4 ]
George, B. [1 ]
机构：
[1] Med Coll Wisconsin, Hematol & Oncol, Milwaukee, WI USA
[2] Med Coll Wisconsin, Med, Milwaukee, WI USA
[3] Med Coll Wisconsin, Biomed Informat, Milwaukee, WI USA
[4] Med Coll Wisconsin, Biostat, Milwaukee, WI USA
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
265
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [21] The roles of ARID1A in gynecologic cancer
    Mao, Tsui-Lien
    Shih, Ie-Ming
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2013, 24 (04) : 376 - 381
  • [22] Remodeling of the ARID1A tumor suppressor
    Luo, Qingyu
    Wu, Xiaowei
    Liu, Zhihua
    CANCER LETTERS, 2020, 491 : 1 - 10
  • [23] Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors
    Han, Xu
    Chen, Wenqi
    Chen, Pingping
    Zhou, Wentao
    Rong, Yefei
    Lv, Yang
    Li, Jian-ang
    Ji, Yuan
    Chen, Wei
    Lou, Wenhui
    Xu, Xuefeng
    PANCREAS, 2020, 49 (04) : 514 - 523
  • [24] Downregulation of ARID1A in colorectal cancer
    Iwata, Yoshinori
    Asano, Yoshimi
    Tanahashi, Toshiyuki
    Mori, Ryutaro
    Matsui, Satoshi
    Imai, Hisashi
    Tanaka, Yoshihiro
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yamaguchi, Kazuya
    Futamura, Manabu
    Takeuchi, Tamotsu
    Yoshida, Kazuhiro
    CANCER SCIENCE, 2018, 109 : 1235 - 1235
  • [25] Loss of ARID1A 'loops' in STING
    Goswami, Sangeeta
    Sharma, Padmanee
    TRENDS IN IMMUNOLOGY, 2024, 45 (08) : 568 - 570
  • [26] The Prognostic Impact of ARID1A Alteration in a Cohort of Molecular Classified Endometrial Carcinomas
    De Leo, Antonio
    de Biase, Dario
    Coluccelli, Sara
    Dondi, Giulia
    De Iaco, Pierandrea
    Perrone, Anna Myriam
    Santini, Donatella
    Tallini, Giovanni
    Ceccarelli, Claudio
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1038 - 1038
  • [27] The Prognostic Impact of ARID1A Alteration in a Cohort of Molecular Classified Endometrial Carcinomas
    De Leo, Antonio
    de Biase, Dario
    Coluccelli, Sara
    Dondi, Giulia
    De Iaco, Pierandrea
    Perrone, Anna Myriam
    Santini, Donatella
    Tallini, Giovanni
    Ceccarelli, Claudio
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1038 - 1038
  • [28] ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer
    Kuroda, Yuka
    Chiyoda, Tatsuyuki
    Kawaida, Miho
    Nakamura, Kohei
    Aimono, Eriko
    Yoshimura, Takuma
    Takahashi, Mio
    Saotome, Keiko
    Yoshihama, Tomoko
    Iwasa, Naomi
    Sakai, Kensuke
    Yamagami, Wataru
    Nishihara, Hiroshi
    Aoki, Daisuke
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 679 - 685
  • [29] Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance
    Berns, Katrien
    Sonnenblick, Amir
    Gennissen, Annemiek
    Brohee, Sylvain
    Hijmans, E. Marielle
    Evers, Bastiaan
    Fumagalli, Debora
    Desmedt, Christine
    Loibl, Sibylle
    Denkert, Carsten
    Neven, Patrick
    Guo, Wei
    Zhang, Fan
    Knijnenburg, Theo A.
    Bosse, Tjalling
    van der Heijden, Michiel S.
    Hindriksen, Sanne
    Nijkamp, Wouter
    Wessels, Lodewyk F. A.
    Joensuu, Heikki
    Mills, Gordon B.
    Beijersbergen, Roderick L.
    Sotiriou, Christos
    Bernards, Rene
    CLINICAL CANCER RESEARCH, 2016, 22 (21) : 5238 - 5248
  • [30] Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Cancers
    Nazeran, Tayyebeh
    Mason, Madeline
    Lee, Sandra
    Gibson-Wright, Bronwyn
    Milne, Katy
    Goode, Ellen
    Ramus, Susan
    Huntsman, David
    Nelson, Brad
    Talhouk, Aline
    Kobel, Martin
    Anglesio, Michael
    LABORATORY INVESTIGATION, 2019, 99
12345